Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone

British Journal of Anaesthesia

Volumn 80, Issue 3, 1998, Pages 386-388

  Driessen, J J ^a   Robertson, E N ^a   Booij, L H D J ^a   Vree, T B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anticonvulsants; Kidney, failure; Neuromuscular block, rocuronium; Pharmacokinetics, rocuronium

Indexed keywords

ANTICONVULSIVE AGENT; NEUROMUSCULAR BLOCKING AGENT; PRIMIDONE; ROCURONIUM; VALPROIC ACID;

ADULT; ANESTHETIC RECOVERY; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DRUG CLEARANCE; DRUG ELIMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 0031930451     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/80.3.386     Document Type: Article

References (16)

1. Alloul K, Whalley DG, Shutway F, Ebrahim Z, Varin F. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology 1996; 84: 330-339.
2. Hickey DR, Sangwan S, Bevan JC. Phenytoin-induced resistance to pancuronium. Anaesthesia 1988; 43: 757-759.
3. Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J. The effects of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987; 67: 191-197.
4. Platt PA, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesthesia and Intensive Care 1993; 21: 185-191.
5. Whalley DG, Ebrahim Z. Influence of carbamazepine on the dose-response relationship of vecuronium. British Journal of Anaesthesia 1994; 72: 125-126.
6. Kleef UW, Proost JH, Roggeveld J, Wierda JMKH. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. Journal of Chromatography 1993; 621: 65-76.
7. Proost JH, Meyer DKW. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Computers in Biological Medicine 1992; 22: 155-163.
8. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMKH, Brady M, Fitzpatrick KTJ. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. British Journal of Anaesthesia 1993; 71: 222-226.
9. Szenohradszky J, Caldwell JE, Sharma ML, Gruenke LD, Miller RD. Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: a possible pharmacokinetic mechanism? Anesthesiology 1994; 80: 1167-1170.
10. Loan PB, Connolly FM, Mirakhur RK, Kumar N, Farling P. Neuromuscular effects of rocuronium in patients receiving beta-adrenoceptor blocking, calcium entry blocking and anticonvulsant drugs. British Journal of Anaesthesia 1997; 78: 90-91.
11. Pollard BJ. Drug Interactions. In: Harper NJN, Pollard BJ, eds. Muscle Relaxants in Anaesthesia. London: Edward Arnold, 1995; 177-197.
12. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-843.
13. Levy RH, Koch KM. Drug interactions with valproic acid. Drugs 1982; 24: 543-56.
14. Ornstein E, Matteo RS, Weinstein JA, Halevy JD, Young WL, Abou-Donia MM. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. Journal of Clinical Anesthesia 1991; 3: 108-111.
15. Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkänen U. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. European Journal of Clinical Pharmacology 1982; 22: 441-445.
16. Crul JF, Vree TB. Neuromuscular blocking agents. In: Stoeckel H, ed. Quantitation, Modelling and Control in Anaesthesia. Stuttgart: Thieme Verlag, 1985; 219-231.